IBM

Microsoft’s latest quarter: Warts on display; Opportunities on the horizon I don’t usually write about specific quarterly results for different companies. I realize that many readers are anxious to see an evaluation of quarterly results in the shortest possible time. I used to do that as part of my job as a brokerage analyst; for the most…

To access this post, you must subscribe.

Read More

We made a change in our income/stability portfolio earlier today. As we had some technical issues with the site, we are sending out this notice in arrears. I am sorry it has been delayed. We sold our 900 share position of HPE at $13.09 which raised about $11,770. We used the proceeds to initiate a…

To access this post, you must subscribe.

Read More

Salesforce-A recommendation for a perilous market The title of this article comes from a quote by Ray Bradbury, a well known author, whose most famous work was “Fahrenheit 451.” I thought it particularly appropriate after the months of share price bloodletting.  I have not written about Salesforce (CRM) on the SA platform for about 4 years now. I…

To access this post, you must subscribe.

Read More

This has been a newsworthy week in terms of corporate developments in the IT world. Of course for the Ticker Target Hi-Growth Portfolio, the most signal event was the strong, pre-announced results of Alteryx that have driven the shares up about 25%. But there have been some other interesting developments that may be tradeable events…

To access this post, you must subscribe.

Read More

Summary IBM has been one of the poorest performing enterprise IT companies for years now. This was the first quarter in which new CEO, Arvind Krishna was the company CEO. The company announced what can best be described as a mixed quarter with plenty of winds-both head and tail to consider. Not terribly surprisingly the…

To access this post, you must subscribe.

Read More

The news that most people watch is about the progress that has been made against the Covid-19 virus. Frankly, some of it seem ghoulish to me, and more like the plot for a Hollywood movie. I suppose today’s journalists and media imagine that this is what their audience wants to read and see. But in…

To access this post, you must subscribe.

Read More

The first few earnings relating to the quarter that ended in December have been published now. They were all beats, and beats in terms of revenue as well as EPS. IBM even managed to post organic growth-although 0.1% is hardly enough to make most investors sit-up and take notice. Thematically, the fact is that last…

To access this post, you must subscribe.

Read More

Melt-ups-should readers take some profits? I have gotten quite a number of questions regarding what readers ought to do in the wake of the melt-up over the past several weeks. I try to avoid making market calls; my own experience is that for every accurate call made by a market strategist,  another one fails. I…

To access this post, you must subscribe.

Read More

One subscriber wrote me that last week was a “hell of a week.” And so it was. I read a drumbeat of articles talking about bubbles and over-valuation. I have presented my thesis often enough. When I write articles and present investment ideas, I try to do so on the basis of logic and not…

To access this post, you must subscribe.

Read More

Summary IBM’s earnings release last week was well received and the shares have further appreciated after a strong YTD performance. IBM once again missed its revenue targets. IBM has provided a minimum of guidance with the expectation of fleshing out expectations on 8/2 when it discusses its post Red Hat future. A careful inspection of…

To access this post, you must subscribe.

Read More